Showing 321-330 of 9323 results for "".
Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators, Part II
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators-part-ii/21593/Experts from different arenas in cosmetic dermatology discuss current and future developments.Business Advisor: Protect Your Practice With Online Reputation Management Strategies
https://practicaldermatology.com/topics/general-topics/business-advisor-protect-your-practice-with-online-reputation-management-strategies/21943/Online communication has affected how patients view physicians and practices. Learn how to know who is saying what about you on the Internet and what to do about itNatural Ingredients and Their Applications in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/natural-ingredients-and-their-applications-in-dermatology/22022/Understanding the role of natural ingredients in therapeutic regimens may help physicians to harness these agents for maximum effect.Expanding the Field: A New Botulinum Neurotoxin A Enters The US Arena
https://practicaldermatology.com/topics/general-topics/PD0609_07-php/22816/A cosmetic dermatologist with experience using Dysport describes how clinicians may approach the new agent in practice.Is Bone Mineral Density Testing Indicated with Long-Term IM Triamcinolone Acetonide Therapy?
https://practicaldermatology.com/topics/general-topics/PD1208_05-php/22603/Prospective data are lacking, but early findings suggest little if any risk of density-loss among patients on long-term therapy.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuComorbidities in Alopecia Areata
https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/Alopecia areata (AA) is a chronic, relapsing immune-mediated disorder that causes nonscarring hair loss that can significantly impact a patient’s quality of life.How May Biosimilars Affect the Treatment of Psoriasis?
https://practicaldermatology.com/topics/psoriasis/how-may-biosimilars-affect-the-treatment-of-psoriasis/23867/The answer depends on several factors.Six Financial Actions to Take During the COVID-19 Crisis
https://practicaldermatology.com/topics/practice-management/six-financial-actions-to-take-during-the-covid-19-crisis/23293/Tips to help weather the storm and prepare for better days ahead.New Effort Seeks to Address Antibiotic Resistance Via Legislation
https://practicaldermatology.com/topics/practice-management/new-effort-seeks-to-address-antibiotic-resistance-via-legislation/23125/Senators seek to support innovation and encourage responsible antibiotic prescribing.